Sign In
Buy VRTX
$428.34
+3.25 (+0.765%)
At Close: Jun 03, 2026
Biotech Hasn't Been This Blazing Hot Since Early 2021 — Here Are The Top 5
12:24pm, Wednesday, 14'th Dec 2022
The top five biotech stocks today have several commonalities: strong ratings. Some also show promising charts and are Tech Leaders.
Here's Why Vertex Pharmaceuticals (VRTX) is a Strong Growth Stock
11:17am, Wednesday, 14'th Dec 2022
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Vertex (VRTX) to Start Clinical Study on mRNA-based CF Therapy
12:02pm, Tuesday, 13'th Dec 2022
Following clearance of the IND application by the FDA, Vertex (VRTX) intends to start a clinical study evaluating a single ascending dose of VX-522 in cystic fibrosis patients in the coming weeks.
NASDAQ Stocks For The Santa Claus Rally
08:18am, Tuesday, 13'th Dec 2022
Here are strong NASDAQ stocks for the holiday season.
More Likely to 5X First: Johnson & Johnson vs. Vertex Pharmaceuticals
07:08am, Tuesday, 13'th Dec 2022
This contest isn't even close.
3 High-Flying Stocks to Buy and Hold If a Recession Is on the Way
05:57am, Tuesday, 13'th Dec 2022
An economic downturn shouldn't hurt these stocks.
3 Non-Energy S&P 500 Stocks With Enough Energy to Boost Returns
09:47am, Monday, 12'th Dec 2022
Though energy companies have been among the best-performing stocks in the S&P 500 index, here we discuss some top-performing non-energy S&P 500 stocks like MRK, VRTX and MCK.
Vertex and CRISPR Therapeutics to Present at the American Society of Hematology (ASH) Annual Meeting and Exposition
08:00am, Saturday, 10'th Dec 2022
BOSTON and ZUG, Switzerland--( BUSINESS WIRE )--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and CRISPR Therapeutics (Nasdaq: CRSP) today announced an oral, encore presentation of clinical data
3 High-Flying Stocks in 2022 That Should Keep Soaring in 2023
06:10am, Saturday, 10'th Dec 2022
These stocks' tailwinds should continue blowing in the new year.
Our 7 Top Biotech Stock Picks for 2023
05:42pm, Friday, 09'th Dec 2022
If there's a silver lining regarding the coronavirus pandemic, it's that it demonstrated the importance of the top biotech stock picks for 2023. While medical innovations may seem frustratingly slow,
3 Reasons Growth Investors Will Love Vertex (VRTX)
02:18pm, Thursday, 08'th Dec 2022
Vertex (VRTX) could produce exceptional returns because of its solid growth attributes.
2 Sector ETFs Hovering Around a 52-Week High
02:18pm, Tuesday, 06'th Dec 2022
We all know that Wall Street is shattered this year. Still, two sectors -- Biotech and Aerospace -- have recently hit a 52-week high.
3 Stocks to Buy Before 2023 That Can Set You Up for Life
10:53am, Tuesday, 06'th Dec 2022
These stocks are already good buys right now.
Is It Too Late to Buy Vertex Pharmaceuticals Stock?
10:00am, Tuesday, 06'th Dec 2022
The company has already made plenty of investors happy.
GSK's Myelofibrosis Candidate MAA Gets Accepted in Europe
12:02pm, Monday, 05'th Dec 2022
GSK's new drug application (NDA) for momelotinib is under standard FDA review, with a decision expected on Jun 16, 2023.
